4//SEC Filing
Panzara Michael A. 4
Accession 0000899243-22-007059
CIK 0001631574other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 6:00 PM ET
Size
5.8 KB
Accession
0000899243-22-007059
Insider Transaction Report
Form 4
Panzara Michael A.
Franchise Lead, Neurology
Transactions
- Sale
Ordinary Shares
2022-02-16$2.31/sh−10,603$24,493→ 75,817 total
Footnotes (2)
- [F1]On February 16, 2022, the reporting person sold 10,603 ordinary shares solely to cover taxes associated with the vesting of restricted share units ("RSUs") on February 15, 2022. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations.
- [F2]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $2.31 to $2.38 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001679039
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 6:00 PM ET
- Size
- 5.8 KB